Pricing Log in Create free account

Enlivex Ltd. (ENLV) vs Xenetic Biosciences, Inc. (XBIO)

Enlivex Ltd. and Xenetic Biosciences, Inc. are both Biotechnology companies. Enlivex Ltd. and Xenetic Biosciences, Inc. are of similar size ($4.7M and $4.5M). Xenetic Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Enlivex Ltd. has the higher net margin (0.00% vs −75.9%) and the lower return on invested capital (−5.85% vs 0.00%). Across the 15 metrics below, Enlivex Ltd. leads on 9 and Xenetic Biosciences, Inc. on 6.

Valuation

Metric ENLV XBIO Biotechnology median
P/E 0.00 n/m 8.50
P/S n/m 1.39 9.71
P/B 0.00 0.75 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 240.66 0.30 0.64
EV/Sales n/m (0.24) 9.21
Earnings yield 248,526.43% (58.59%) (33.15%)
Free cash flow yield (301.79%) (50.87%) (25.50%)

Profitability

Metric ENLV XBIO Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (81.01%) 0.00%
Net margin 0.00% (75.90%) 0.00%
Free cash flow margin 0.00% (70.93%) 0.00%
Return on equity 159.77% (47.05%) (56.36%)
Return on assets 127.16% (40.17%) (48.04%)
Return on invested capital (5.85%) 0.00% 0.00%

Growth

Metric ENLV XBIO Biotechnology median
Revenue growth (TTM) — 33.30% 6.02%
EPS growth (last fiscal year) 3,590.26% 38.52% 30.26%
Revenue growth, 5-year CAGR — 46.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV XBIO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 119.39 7.43 4.72
Net debt to EBITDA 118.29 2.78 0.96

Dividend

Metric ENLV XBIO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENLV XBIO Biotechnology median
Market cap 4.46m 4.71m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack